NeuPath Health Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was CAD 15.94 million compared to CAD 15.93 million a year ago. Net loss was CAD 0.339 million compared to CAD 1.15 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.03 a year ago.
For the six months, revenue was CAD 31.35 million compared to CAD 30.12 million a year ago. Net loss was CAD 1.25 million compared to CAD 1.85 million a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.04 a year ago.